Shares of Stem, Inc. (NYSE:STEM - Get Free Report) have been given a consensus rating of "Hold" by the nine analysts that are presently covering the company, MarketBeat.com reports. Eight equities research analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $1.11.
Several equities research analysts recently commented on the stock. Susquehanna boosted their price objective on shares of Stem from $0.40 to $0.60 and gave the stock a "neutral" rating in a research note on Thursday, May 1st. UBS Group restated a "neutral" rating on shares of Stem in a report on Monday, April 14th. BMO Capital Markets decreased their price objective on shares of Stem from $0.50 to $0.40 and set a "market perform" rating for the company in a report on Wednesday, March 5th. Finally, Roth Mkm boosted their target price on shares of Stem from $0.35 to $0.40 and gave the company a "neutral" rating in a research note on Wednesday, March 5th.
View Our Latest Stock Analysis on STEM
Stem Stock Performance
NYSE:STEM traded up $0.01 during trading hours on Friday, reaching $0.47. The company's stock had a trading volume of 138,161 shares, compared to its average volume of 7,315,314. The firm has a market capitalization of $77.64 million, a price-to-earnings ratio of -0.09 and a beta of 1.42. The firm has a 50-day simple moving average of $0.43 and a 200-day simple moving average of $0.49. Stem has a 1 year low of $0.29 and a 1 year high of $1.68.
Stem (NYSE:STEM - Get Free Report) last released its quarterly earnings data on Tuesday, April 29th. The company reported ($0.15) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.20) by $0.05. The firm had revenue of $32.51 million for the quarter, compared to analysts' expectations of $28.59 million. Stem had a negative net margin of 328.11% and a negative return on equity of 275.79%. Equities analysts anticipate that Stem will post -0.52 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Stem
A number of hedge funds have recently modified their holdings of the business. Electron Capital Partners LLC grew its position in shares of Stem by 24.7% during the 1st quarter. Electron Capital Partners LLC now owns 163,390 shares of the company's stock valued at $57,000 after acquiring an additional 32,313 shares during the period. AQR Capital Management LLC boosted its holdings in Stem by 505.8% in the 1st quarter. AQR Capital Management LLC now owns 1,482,790 shares of the company's stock worth $519,000 after buying an additional 1,238,012 shares during the period. Nomura Holdings Inc. boosted its holdings in Stem by 24.1% in the 1st quarter. Nomura Holdings Inc. now owns 228,814 shares of the company's stock worth $80,000 after buying an additional 44,433 shares during the period. Hsbc Holdings PLC boosted its holdings in Stem by 5.6% in the 1st quarter. Hsbc Holdings PLC now owns 873,282 shares of the company's stock worth $307,000 after buying an additional 46,573 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Stem by 22.0% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 444,053 shares of the company's stock worth $156,000 after buying an additional 80,000 shares during the period. Institutional investors own 61.63% of the company's stock.
About Stem
(
Get Free ReportStem, Inc operates as a digitally connected, intelligent, and renewable energy storage network provider worldwide. The company offers energy storage hardware sourced from original equipment manufacturers (OEMs); edge hardware to aid in the collection of site data and real-time operation and control of the site and other optional equipment; and Athena, a software platform, which offers battery hardware and software-enabled services to operate the energy storage systems.
Further Reading

Before you consider Stem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stem wasn't on the list.
While Stem currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.